Gert van Houwelingen
Overview
Explore the profile of Gert van Houwelingen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kok M, Zocca P, Buiten R, Danse P, Schotborgh C, Scholte M, et al.
EuroIntervention
. 2018 May;
14(8):915-923.
PMID: 29790480
Aims: The aim of the study was to evaluate the two-year clinical outcome of all-comer trial participants who were treated with two very different thin-strut biodegradable polymer versus thin-strut durable...
2.
van Dongen I, Elias J, van Houwelingen G, Agostoni P, Hoebers L, Ouweneel D, et al.
JACC Cardiovasc Interv
. 2018 Mar;
11(5):511-512.
PMID: 29519390
No abstract available.
3.
Kok M, von Birgelen C, Sattar N, Zocca P, Lowik M, Danse P, et al.
EuroIntervention
. 2018 Jan;
14(9):e1049-e1056.
PMID: 29313817
Aims: It is unclear whether detection of prediabetes (pre-DM) by routine assessment of glycated haemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) among patients undergoing percutaneous coronary intervention (PCI) with...
4.
Oude Velthuis B, van Es J, van Houwelingen G, Toes G, Wagenaar L
J Am Coll Cardiol
. 2012 Nov;
60(19):e35.
PMID: 23117105
No abstract available.
5.
Hermanides R, Ottervanger J, Ten Berg J, Gosselink A, van Houwelingen G, Dambrink J, et al.
J Invasive Cardiol
. 2012 Mar;
24(3):84-9.
PMID: 22388296
Aims: The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods:...
6.
Heestermans T, de Boer M, van Werkum J, Mosterd A, Gosselink A, Dambrink J, et al.
EuroIntervention
. 2011 Jul;
7(4):442-8.
PMID: 21764662
Aims: To evaluate the impact of longer duration of pre-hospital initiated antiplatelet and antithrombotic therapy on outcome in patients with ST-segment elevation myocardial infarction (STEMI). Methods And Results: In this...
7.
Hermanides R, van Houwelingen G, Ottervanger J, de Boer M, Dill T, Hamm C, et al.
Cardiovasc Drugs Ther
. 2011 Jul;
25(4):323-30.
PMID: 21744314
Purpose: Glycoprotein IIb/IIIa inhibitors are favourable in ST-elevation myocardial infarction (STEMI) patients, and the additional value of early pre-hospital high bolus dose tirofiban has recently been established. The aim of...
8.
Hermanides R, Ottervanger J, Dambrink J, Dill T, van Houwelingen G, Ten Berg J, et al.
Int J Cardiol
. 2011 Jan;
157(1):86-90.
PMID: 21194762
Background: In most patients with ST-elevation myocardial infarction (STEMI), antiplatelet drugs are already administrated in the ambulance, before hospital admission. We investigated the safety of prehospital initiation of a high...
9.
Heestermans T, Suryapranata H, Ten Berg J, Mosterd A, Gosselink A, Kochman W, et al.
J Electrocardiol
. 2010 Dec;
44(1):42-8.
PMID: 21168000
Objective: The objective of this study is to evaluate the incidence, predictors, and outcome of complete ST-segment resolution (STR) during transportation after pretreatment with dual or triple antiplatelet therapy in...
10.
Heestermans T, van t Hof A, Ten Berg J, van Werkum J, Boersma E, Mosterd A, et al.
Am Heart J
. 2010 Dec;
160(6):1079-84.
PMID: 21146661
Background: It is known that the efficacy of thrombolytic therapy in ST-segment elevation myocardial infarction (STEMI) is highly time dependent with the best efficacy when given within the so-called golden...